Sec. 303. Increasing access to medication for opioid overdose reversal; exemption from requirements of the Drug Supply Chain Security Act

136 words·~1 min read·/bill/118/s/1785/is/section-303

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 581(24)(B) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360eee(24)(B) ) is amended— by redesignating clauses

(xvii)and (xviii) as clauses (xviii) and (xix), respectively; and by inserting after clause

(xvi)the following: the distribution of an opioid antagonist indicated for emergency treatment of opioid overdose, such as naloxone, by or to an overdose prevention, syringe services program, or other harm reduction service; . Section 503(e)(4) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 353(e)(4) ) is amended— by redesignating subparagraphs

(R)and

(S)as subparagraphs

(S)and (T), respectively; and by inserting after subparagraph

(Q)the following: the distribution of an opioid antagonist indicated for emergency treatment of opioid overdose, such as naloxone, by or to an overdose prevention, syringe services program, or other harm reduction service; .

Connectionstraces to 2

Traces to 2 documents

U.S. Code

Citation graph

cites case law

Sec. 303

Increasing access to medication for opioid overdose reversal; exemption from requirements of the Drug Supply Chain Security Act

U.S.C.§ 360eee

U.S.C.§ 353

Cites 2Cited by 0 across 0 sources